| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 1.32e-10 | 5 | 213 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | chloride ion binding | 1.50e-10 | 16 | 213 | 7 | GO:0031404 | |
| GeneOntologyMolecularFunction | amylase activity | 7.84e-10 | 6 | 213 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.47e-05 | 103 | 213 | 8 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.60e-04 | 144 | 213 | 8 | GO:0016798 | |
| GeneOntologyBiologicalProcess | fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate | 4.37e-06 | 4 | 214 | 3 | GO:0061624 | |
| GeneOntologyBiologicalProcess | fructose catabolic process | 1.08e-05 | 5 | 214 | 3 | GO:0006001 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 8.26e-05 | 23 | 215 | 4 | GO:0005797 | |
| Domain | Alpha_amylase | 1.74e-08 | 4 | 216 | 4 | IPR006046 | |
| Domain | Aamy_C | 1.74e-08 | 4 | 216 | 4 | SM00632 | |
| Domain | Alpha-amylase_C | 8.62e-08 | 5 | 216 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 8.62e-08 | 5 | 216 | 4 | IPR006048 | |
| Domain | Glyco_hydro_b | 5.40e-07 | 15 | 216 | 5 | IPR013780 | |
| Domain | Glyco_hydro_13_cat_dom | 5.93e-07 | 7 | 216 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 5.93e-07 | 7 | 216 | 4 | PF00128 | |
| Domain | Aamy | 5.93e-07 | 7 | 216 | 4 | SM00642 | |
| Domain | A-amylase_C | 1.53e-06 | 3 | 216 | 3 | IPR031319 | |
| Domain | FN3 | IL10RB EPHA6 OBSCN PTPRS USH2A FLNC SDK2 KALRN FNDC3A IFNAR1 IL2RG | 1.06e-05 | 185 | 216 | 11 | SM00060 |
| Domain | - | 1.59e-05 | 14 | 216 | 4 | 2.60.40.1180 | |
| Domain | Glyco_hydro_13 | 2.97e-05 | 6 | 216 | 3 | IPR015902 | |
| Domain | Glycoside_hydrolase_SF | 3.26e-05 | 53 | 216 | 6 | IPR017853 | |
| Domain | FN3_dom | IL10RB EPHA6 OBSCN PTPRS USH2A FLNC SDK2 KALRN FNDC3A IFNAR1 IL2RG | 3.31e-05 | 209 | 216 | 11 | IPR003961 |
| Domain | Glyco_hydro_catalytic_dom | 7.27e-05 | 38 | 216 | 5 | IPR013781 | |
| Domain | FN3 | IL10RB EPHA6 OBSCN PTPRS USH2A SDK2 KALRN FNDC3A IFNAR1 IL2RG | 1.11e-04 | 199 | 216 | 10 | PS50853 |
| Domain | NLGN4 | 1.33e-04 | 2 | 216 | 2 | IPR030025 | |
| Domain | Ig-like_fold | IL10RB EPHA6 MYCBP2 HLA-E HLA-F OBSCN PTK7 PTPRS PXDNL USH2A VCAM1 FLNC SDK2 KALRN FNDC3A IFNAR1 SIGLEC7 PRKAB2 LY9 IL2RG | 2.12e-04 | 706 | 216 | 20 | IPR013783 |
| Domain | - | IL10RB EPHA6 MYCBP2 HLA-E HLA-F OBSCN PTK7 PTPRS PXDNL USH2A VCAM1 FLNC SDK2 KALRN FNDC3A IFNAR1 SIGLEC7 LY9 IL2RG | 2.65e-04 | 663 | 216 | 19 | 2.60.40.10 |
| Domain | ARM-like | TOGARAM1 AP2A1 HECTD1 GPRASP2 IPO5 ZYG11A PKP4 RTTN DOCK10 ECPAS WDFY4 | 3.19e-04 | 270 | 216 | 11 | IPR011989 |
| Domain | - | LRTM2 TLR8 LRRIQ1 PXDNL ZYG11A LRRC75B SKP2 OMG TSKU NLRP14 CMIP IGFALS | 3.76e-04 | 321 | 216 | 12 | 3.80.10.10 |
| Domain | L_dom-like | LRTM2 TLR8 LRRIQ1 PXDNL ZYG11A LRRC75B SKP2 OMG TSKU NLRP14 CMIP IGFALS | 4.56e-04 | 328 | 216 | 12 | IPR032675 |
| Domain | - | 4.71e-04 | 119 | 216 | 7 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 4.71e-04 | 119 | 216 | 7 | IPR029058 | |
| Domain | fn3 | 6.06e-04 | 162 | 216 | 8 | PF00041 | |
| Domain | - | 6.88e-04 | 35 | 216 | 4 | 3.20.20.80 | |
| Domain | Galactose-bd-like | 7.80e-04 | 94 | 216 | 6 | IPR008979 | |
| Domain | Mib_Herc2 | 7.87e-04 | 4 | 216 | 2 | IPR010606 | |
| Domain | MIB_HERC2 | 7.87e-04 | 4 | 216 | 2 | PS51416 | |
| Domain | MIB_HERC2 | 7.87e-04 | 4 | 216 | 2 | PF06701 | |
| Domain | DEAH_ATP_HELICASE | 9.44e-04 | 38 | 216 | 4 | PS00690 | |
| Domain | - | 1.15e-03 | 222 | 216 | 9 | 1.25.10.10 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 1.07e-10 | 9 | 150 | 6 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 5.60e-08 | 11 | 150 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 3.68e-06 | 23 | 150 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.03e-05 | 28 | 150 | 5 | M27837 | |
| Pathway | REACTOME_FRUCTOSE_CATABOLISM | 1.16e-05 | 5 | 150 | 3 | MM15395 | |
| Pathway | REACTOME_FRUCTOSE_CATABOLISM | 1.16e-05 | 5 | 150 | 3 | M27675 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.79e-05 | 52 | 150 | 6 | M14171 | |
| Pathway | REACTOME_FRUCTOSE_METABOLISM | 4.01e-05 | 7 | 150 | 3 | M27506 | |
| Pathway | REACTOME_FRUCTOSE_METABOLISM | 4.01e-05 | 7 | 150 | 3 | MM15231 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 6.36e-05 | 8 | 150 | 3 | MM14717 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAPGEF6 ACACA MYCBP2 PPRC1 OBSCN FYCO1 PPP1R26 JAK2 GDPD5 EIF4ENIF1 AP2A1 PTPRS AHNAK TLN2 HECTD1 PRRC2B FLNC SHROOM3 KALRN MEX3D RTTN ST3GAL1 PPP6R1 TNRC6C ECE1 TEP1 MBD3 SLC2A1 TKFC ZNF827 CHD5 LRP4 PCNT | 1.26e-13 | 1105 | 219 | 33 | 35748872 |
| Pubmed | 5.65e-11 | 6 | 219 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 5.65e-11 | 6 | 219 | 5 | 2788608 | |
| Pubmed | 5.65e-11 | 6 | 219 | 5 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 5.65e-11 | 6 | 219 | 5 | 6608795 | |
| Pubmed | 5.65e-11 | 6 | 219 | 5 | 2081604 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EOGT ACACA EPHA6 NUMBL MYCBP2 TSHZ2 TBC1D5 OBSCN TSNAX STEAP2 PTK7 JAK2 PTPRS MME HECTD1 DAGLA SHROOM3 NLGN4Y PPFIBP2 APBB2 RNF213 ST3GAL1 TNRC6C ECPAS TEP1 CMIP ZNF827 PNPLA7 TANGO2 CSMD1 DOP1A CPNE7 PCNT | 3.44e-10 | 1489 | 219 | 33 | 28611215 |
| Pubmed | 5.22e-10 | 8 | 219 | 5 | 12414807 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 5.22e-10 | 8 | 219 | 5 | 7523515 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CYLD KDM3A USP45 MYCBP2 NOL6 PSMD13 TSNAX NUP205 ALDH16A1 SNX27 HECTD1 PLRG1 GPRASP2 PRRC2B IPO5 TOR1AIP2 FLNC WRN YTHDC2 PPP6R1 DPP3 SKP2 YARS2 POLR3E EIF3B CPNE7 | 1.31e-09 | 1005 | 219 | 26 | 19615732 |
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 1.53e-09 | 4 | 219 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 1.53e-09 | 4 | 219 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 1.53e-09 | 4 | 219 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 1.53e-09 | 4 | 219 | 4 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 1.53e-09 | 4 | 219 | 4 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 1.53e-09 | 4 | 219 | 4 | 94264 | |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 3872721 | ||
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 1.53e-09 | 4 | 219 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 1.53e-09 | 4 | 219 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 1.53e-09 | 4 | 219 | 4 | 2987507 | |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 6091898 | ||
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 1.53e-09 | 4 | 219 | 4 | 6162108 | |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 16152770 | ||
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 2423416 | ||
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 1.53e-09 | 4 | 219 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 1.53e-09 | 4 | 219 | 4 | 2989529 | |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 1.53e-09 | 4 | 219 | 4 | 1141004 | |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 1.53e-09 | 4 | 219 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 1.53e-09 | 4 | 219 | 4 | 6207174 | |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 1.53e-09 | 4 | 219 | 4 | 2332419 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 6529441 | ||
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 7.61e-09 | 5 | 219 | 4 | 34276419 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 7.61e-09 | 5 | 219 | 4 | 8661735 | |
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 2002257 | ||
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 2.27e-08 | 6 | 219 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 2.27e-08 | 6 | 219 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 2.27e-08 | 6 | 219 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 2.27e-08 | 6 | 219 | 4 | 7859283 | |
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 2.27e-08 | 6 | 219 | 4 | 1021597 | |
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 5.28e-08 | 7 | 219 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 5.28e-08 | 7 | 219 | 4 | 2451911 | |
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 7949740 | ||
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 6160178 | ||
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 8604219 | ||
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 8666240 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 2040456 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 3038891 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 8486361 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 1.05e-07 | 8 | 219 | 4 | 6200103 | |
| Pubmed | 1.88e-07 | 9 | 219 | 4 | 93520 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 2.46e-07 | 3 | 219 | 3 | 2413838 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 2.46e-07 | 3 | 219 | 3 | 21827821 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 2.46e-07 | 3 | 219 | 3 | 6360562 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 2.46e-07 | 3 | 219 | 3 | 2436036 | |
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 2.46e-07 | 3 | 219 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 2.46e-07 | 3 | 219 | 3 | 17223109 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 15299664 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 8413315 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 2.46e-07 | 3 | 219 | 3 | 7678001 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 6098446 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 30982860 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 1699843 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 12527308 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 2414282 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 28659346 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 25588701 | ||
| Pubmed | 3.12e-07 | 10 | 219 | 4 | 9121556 | ||
| Pubmed | 3.12e-07 | 10 | 219 | 4 | 2897103 | ||
| Pubmed | 3.65e-07 | 24 | 219 | 5 | 22529374 | ||
| Pubmed | A2M ACACA PPRC1 BCAS2 NOL6 GLYCTK NIF3L1 TMEM214 NUP205 MED24 BRCA2 PLRG1 SHROOM3 FNDC3A ECPAS ECE1 MBD3 ZFP37 PPIL1 | 3.67e-07 | 754 | 219 | 19 | 35906200 | |
| Pubmed | KDM3A MAN2A1 MYCBP2 HLA-F FYCO1 PSMD13 NUP205 EIF4ENIF1 AP2A1 AHNAK ALDH16A1 CORO7 PIGO IPO5 DOCK10 RNF213 FNDC3A ST3GAL1 ECPAS ECE1 CHD5 PRR11 IL2RG PCNT | 4.24e-07 | 1168 | 219 | 24 | 19946888 | |
| Pubmed | 4.88e-07 | 11 | 219 | 4 | 23449223 | ||
| Pubmed | 4.88e-07 | 11 | 219 | 4 | 7608209 | ||
| Pubmed | 4.88e-07 | 11 | 219 | 4 | 1617215 | ||
| Pubmed | 4.88e-07 | 11 | 219 | 4 | 2903254 | ||
| Pubmed | 4.88e-07 | 11 | 219 | 4 | 2565740 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 4.88e-07 | 11 | 219 | 4 | 7493641 | |
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 4.88e-07 | 11 | 219 | 4 | 8589528 | |
| Pubmed | 7.28e-07 | 12 | 219 | 4 | 8144363 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 2458567 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 20939500 | ||
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 9.81e-07 | 4 | 219 | 3 | 8543783 | |
| Pubmed | An amylase/Cre transgene marks the whole endoderm but the primordia of liver and ventral pancreas. | 9.81e-07 | 4 | 219 | 3 | 16786601 | |
| Pubmed | 1.05e-06 | 13 | 219 | 4 | 489953 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 1.05e-06 | 13 | 219 | 4 | 7829080 | |
| Pubmed | CYLD KNTC1 RAPGEF6 TBC1D5 EIF4ENIF1 AP2A1 HECTD1 SHROOM3 PKP4 PPP6R1 ECPAS NCKAP5L SKP2 FAM193A | 1.07e-06 | 446 | 219 | 14 | 24255178 | |
| Interaction | TOP3B interactions | RAPGEF6 ACACA MYCBP2 PPRC1 OBSCN FYCO1 TSNAX PPP1R26 JAK2 GDPD5 EIF4ENIF1 AP2A1 PTPRS CIAO1 AHNAK MIB1 TLN2 HECTD1 PRRC2B IPO5 FLNC SHROOM3 KALRN MEX3D RTTN WRN ST3GAL1 PPP6R1 TNRC6C ECE1 TEP1 MBD3 SLC2A1 TKFC ZNF827 CHD5 LRP4 PCNT | 2.69e-07 | 1470 | 214 | 38 | int:TOP3B |
| Cytoband | 1p21 | 9.32e-08 | 24 | 219 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 1.33e-05 | 107 | 219 | 6 | chr1p21 | |
| GeneFamily | Fibronectin type III domain containing | 2.56e-05 | 160 | 134 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.99e-04 | 161 | 134 | 7 | 593 | |
| GeneFamily | WD repeat domain containing | 7.57e-04 | 262 | 134 | 8 | 362 | |
| GeneFamily | Myb/SANT domain containing|NineTeen complex | 1.12e-03 | 7 | 134 | 2 | 1361 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_UP | 3.12e-06 | 106 | 219 | 8 | MM595 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | A2M CYLD KNTC1 MAN2A1 HLA-E HLA-F JAK2 AMY1B AMY1C AMY2A AMY2B | 5.89e-06 | 239 | 219 | 11 | MM1274 |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 1.58e-05 | 132 | 219 | 8 | MM470 | |
| Coexpression | GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP | 3.49e-05 | 191 | 219 | 9 | M3298 | |
| Coexpression | GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP | 4.80e-05 | 199 | 219 | 9 | M8080 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAST_CELL_UP | 4.80e-05 | 199 | 219 | 9 | M5397 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP | 4.99e-05 | 200 | 219 | 9 | M9652 | |
| Coexpression | GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN | 4.99e-05 | 200 | 219 | 9 | M4885 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 4.99e-05 | 200 | 219 | 9 | M8967 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 4.99e-05 | 200 | 219 | 9 | M9215 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.89e-06 | 186 | 218 | 8 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.38e-06 | 189 | 218 | 8 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-06 | 189 | 218 | 8 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 4.92e-06 | 192 | 218 | 8 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.94e-06 | 197 | 218 | 8 | a72047b7428c0d4aaf016c1ac23dc30919260fd8 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.17e-06 | 198 | 218 | 8 | bfd720e2dae3b6b3dc2bf8b2096c554fd456e756 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.64e-06 | 200 | 218 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 157 | 218 | 7 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 159 | 218 | 7 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-05 | 159 | 218 | 7 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 163 | 218 | 7 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-05 | 163 | 218 | 7 | 130c84bca3f72ab7d1a4fee2990c3d01600318ed | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 163 | 218 | 7 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-05 | 166 | 218 | 7 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-05 | 166 | 218 | 7 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.18e-05 | 171 | 218 | 7 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 173 | 218 | 7 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 173 | 218 | 7 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 173 | 218 | 7 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 173 | 218 | 7 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 174 | 218 | 7 | 4289dfc7613db4bb3d706b9b65d06e84c0c53558 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 174 | 218 | 7 | 165e14cad57e90aa247dcecfaa3c2e8ff2a470ad | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 2.53e-05 | 175 | 218 | 7 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 2.53e-05 | 175 | 218 | 7 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 176 | 218 | 7 | acd05ca8952710feedbfe377b1330f3c2406d044 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.92e-05 | 179 | 218 | 7 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-05 | 180 | 218 | 7 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 3.06e-05 | 122 | 218 | 6 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-05 | 181 | 218 | 7 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-Memory_B_cells|Liver / Manually curated celltypes from each tissue | 3.13e-05 | 181 | 218 | 7 | a9f4df288c34e3b2b6ed861ac6cda970c3ee08b1 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.36e-05 | 183 | 218 | 7 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.48e-05 | 184 | 218 | 7 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.60e-05 | 185 | 218 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.73e-05 | 186 | 218 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.73e-05 | 186 | 218 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Mesenchymal_cells-Adipo-CAR|World / Lineage and Cell class | 3.73e-05 | 186 | 218 | 7 | 6ca8ce7ced91d6308b7c056032ffec1b37c974bf | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.86e-05 | 187 | 218 | 7 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 188 | 218 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.27e-05 | 190 | 218 | 7 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 191 | 218 | 7 | a261f0738d974784bbdd60f23092bfbcca464459 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 191 | 218 | 7 | 8a73d2df079566fca4cbb5cdb85721c2e87134c8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 191 | 218 | 7 | 6594398cc8151c73696391a43ac110c10283dab1 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 191 | 218 | 7 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 191 | 218 | 7 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.41e-05 | 191 | 218 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.41e-05 | 191 | 218 | 7 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.56e-05 | 192 | 218 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 192 | 218 | 7 | d22c1135867bcb9076435e2c6eb1cc1248990d0c | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 4.56e-05 | 192 | 218 | 7 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.56e-05 | 192 | 218 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 192 | 218 | 7 | c09966f4d63a739a56db4df7e0e0ee9ecacd21ad | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.71e-05 | 193 | 218 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.71e-05 | 193 | 218 | 7 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 4.87e-05 | 194 | 218 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.87e-05 | 194 | 218 | 7 | 87604c93d20f9171e0a1279bdb6ad73fe5fed356 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 5.03e-05 | 195 | 218 | 7 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 5.19e-05 | 196 | 218 | 7 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.19e-05 | 196 | 218 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-05 | 198 | 218 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-05 | 198 | 218 | 7 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.72e-05 | 199 | 218 | 7 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 5.72e-05 | 199 | 218 | 7 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | distal-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.72e-05 | 199 | 218 | 7 | 97b475f9110ef7bb29d9cf2109b7e43177830f05 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.72e-05 | 199 | 218 | 7 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.72e-05 | 199 | 218 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.90e-05 | 200 | 218 | 7 | 2ae62c428728c1d9d4471d4be24bd6ab074fa22c | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.90e-05 | 200 | 218 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.90e-05 | 200 | 218 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.90e-05 | 200 | 218 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.90e-05 | 200 | 218 | 7 | cdaf462b1db29dab61038eeab5ddd3eef3386763 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-13|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.72e-05 | 144 | 218 | 6 | b2a9f3b5dd46d27689467f4a5fd717cd5827821f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-05 | 145 | 218 | 6 | b961b69befb15ff6f58635e0d4bda88ea732a346 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.00e-04 | 151 | 218 | 6 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 158 | 218 | 6 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.29e-04 | 158 | 218 | 6 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 159 | 218 | 6 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 101 | 218 | 5 | 86acaa2502f61baa714ae988b73e3e73a71e897e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-04 | 162 | 218 | 6 | b46158e260bd2f35702cec73e3b035e8e9ec4469 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.47e-04 | 162 | 218 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 165 | 218 | 6 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 165 | 218 | 6 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.68e-04 | 166 | 218 | 6 | 8de8f388f24436b84e19ef460476fdbda4d16abf | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 166 | 218 | 6 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 166 | 218 | 6 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 168 | 218 | 6 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-04 | 168 | 218 | 6 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.80e-04 | 168 | 218 | 6 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.85e-04 | 169 | 218 | 6 | 89fbafdb4628ce7a90c50398870e0f8ee90cfd91 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.85e-04 | 169 | 218 | 6 | 9ab34f602d46ce87283d243b81621e8806504f43 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.85e-04 | 169 | 218 | 6 | 75d367eb35768d3063096e8866cea649dac3b1bd | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-04 | 170 | 218 | 6 | 7dcb6319ba4d7b258dd0a17449d837800ef46ccc | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-04 | 170 | 218 | 6 | 7377e59fba4bf97ba893ccf6b5e149b5152407be | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-04 | 170 | 218 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.91e-04 | 170 | 218 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-04 | 170 | 218 | 6 | e18211029e9ffad54458fd921f455172aad407c7 | |
| ToppCell | Control-B_cell-Plasmablast|Control / Disease group,lineage and cell class （2021.01.30） | 1.98e-04 | 171 | 218 | 6 | c09afc4b111b2b5acca75177554f6364ee02d37c | |
| ToppCell | Severe-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.98e-04 | 171 | 218 | 6 | 61205a4986c2d0a89aea96ed8dec9e952eeb6ff1 | |
| Drug | 4-nitrophenylmaltoheptaoside | 4.17e-11 | 15 | 219 | 7 | CID000173254 | |
| Drug | Glc)4 | 1.50e-10 | 10 | 219 | 6 | CID000189098 | |
| Drug | Ro 20-0083 | 1.50e-10 | 10 | 219 | 6 | CID003082332 | |
| Drug | AC1L3M0Q | 1.50e-10 | 10 | 219 | 6 | CID000118008 | |
| Drug | CNP-G5 | 3.28e-10 | 11 | 219 | 6 | CID000127309 | |
| Drug | R 623 | 4.68e-10 | 6 | 219 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 4.68e-10 | 6 | 219 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 4.68e-10 | 6 | 219 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 4.68e-10 | 6 | 219 | 5 | CID000127364 | |
| Drug | CNP-G3 | 4.68e-10 | 6 | 219 | 5 | CID003082910 | |
| Drug | methyl 1'-epiacarviosin | 1.20e-09 | 13 | 219 | 6 | CID000197426 | |
| Drug | isoacarbose | 1.20e-09 | 13 | 219 | 6 | CID000449165 | |
| Drug | 2-aminopyridine | 1.32e-09 | 70 | 219 | 10 | CID000010439 | |
| Drug | AC1L5BOU | 1.63e-09 | 7 | 219 | 5 | CID000174858 | |
| Drug | 3KBG5CNP | 1.63e-09 | 7 | 219 | 5 | CID003083250 | |
| Drug | BG5P | 1.63e-09 | 7 | 219 | 5 | CID003082752 | |
| Drug | 2-chloro-4-nitrophenol | 2.08e-09 | 14 | 219 | 6 | CID000012074 | |
| Drug | boric acid gel | 4.30e-09 | 8 | 219 | 5 | CID003016474 | |
| Drug | desethylaprophen | 4.30e-09 | 8 | 219 | 5 | CID000163919 | |
| Drug | azintamide | 4.30e-09 | 8 | 219 | 5 | CID000071105 | |
| Drug | gamma-cyclodextrin | 5.46e-09 | 16 | 219 | 6 | CID000086575 | |
| Drug | Bay e 4609 | 5.46e-09 | 16 | 219 | 6 | CID003085308 | |
| Drug | N-PMT | 8.33e-09 | 4 | 219 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 8.33e-09 | 4 | 219 | 4 | CID003482066 | |
| Drug | SAIB-SG | 8.33e-09 | 4 | 219 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 8.33e-09 | 4 | 219 | 4 | CID013573844 | |
| Drug | Dembrexine | 8.33e-09 | 4 | 219 | 4 | CID000072009 | |
| Drug | g lw | 8.33e-09 | 4 | 219 | 4 | CID000444139 | |
| Drug | beta-santalene | 8.33e-09 | 4 | 219 | 4 | CID000010534 | |
| Drug | GU-3 | 9.61e-09 | 9 | 219 | 5 | CID000448687 | |
| Drug | alpha-maltosyl fluoride | 9.61e-09 | 9 | 219 | 5 | CID000194237 | |
| Drug | trestatin A | 9.61e-09 | 9 | 219 | 5 | CID003054994 | |
| Drug | aprophen | 1.25e-08 | 18 | 219 | 6 | CID000071128 | |
| Drug | AC1LAC07 | 1.91e-08 | 10 | 219 | 5 | CID000485275 | |
| Drug | Tempamine | 3.47e-08 | 11 | 219 | 5 | CID000550942 | |
| Drug | validamycin D | 3.47e-08 | 11 | 219 | 5 | CID000166726 | |
| Drug | FG5P | 3.47e-08 | 11 | 219 | 5 | CID000127486 | |
| Drug | HgI2 | 3.47e-08 | 11 | 219 | 5 | CID000024485 | |
| Drug | 2C KM | 3.47e-08 | 11 | 219 | 5 | CID009549196 | |
| Drug | Deposiston | 4.13e-08 | 5 | 219 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 4.13e-08 | 5 | 219 | 4 | CID010358258 | |
| Drug | lunularic acid | 4.13e-08 | 5 | 219 | 4 | CID000161413 | |
| Drug | himachalene | 4.13e-08 | 5 | 219 | 4 | CID000015095 | |
| Drug | actinidine | 4.13e-08 | 5 | 219 | 4 | CID000068231 | |
| Drug | 2TAA | 4.13e-08 | 5 | 219 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 4.13e-08 | 5 | 219 | 4 | CID006449879 | |
| Drug | silver perchlorate | 4.13e-08 | 5 | 219 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 4.13e-08 | 5 | 219 | 4 | CID000155287 | |
| Drug | maltosaccharide | 4.85e-08 | 22 | 219 | 6 | CID005461034 | |
| Drug | azaprophen | 5.90e-08 | 12 | 219 | 5 | CID000129486 | |
| Drug | maltohexaose | 8.20e-08 | 39 | 219 | 7 | CID000439606 | |
| Drug | S-p-nitrobenzyloxycarbonylglutathione | 8.20e-08 | 39 | 219 | 7 | CID004632704 | |
| Drug | Panose B | 8.61e-08 | 24 | 219 | 6 | CID000439297 | |
| Drug | II 13 | 9.51e-08 | 13 | 219 | 5 | CID003040488 | |
| Drug | maltal | 9.51e-08 | 13 | 219 | 5 | CID000169427 | |
| Drug | maltoheptose | 9.85e-08 | 40 | 219 | 7 | CID003037125 | |
| Drug | 2-amino-6-picoline | 1.23e-07 | 6 | 219 | 4 | CID000015765 | |
| Drug | phenol blue | 1.23e-07 | 6 | 219 | 4 | CID000075078 | |
| Drug | Gu-4 | 1.23e-07 | 6 | 219 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 1.23e-07 | 6 | 219 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 1.23e-07 | 6 | 219 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 1.23e-07 | 6 | 219 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 1.23e-07 | 6 | 219 | 4 | CID006857368 | |
| Drug | vermella | 1.23e-07 | 6 | 219 | 4 | CID000203726 | |
| Drug | hymenin | 1.23e-07 | 6 | 219 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 1.23e-07 | 6 | 219 | 4 | CID000011615 | |
| Drug | Cyclodextrins | 1.47e-07 | 14 | 219 | 5 | CID000024238 | |
| Drug | terephthaloyl chloride | 1.47e-07 | 14 | 219 | 5 | CID000007488 | |
| Drug | 2ai8 | 2.18e-07 | 15 | 219 | 5 | CID005289329 | |
| Drug | cellopentaose | 2.30e-07 | 45 | 219 | 7 | CID000440949 | |
| Drug | methyl blue | 2.85e-07 | 7 | 219 | 4 | CID011969534 | |
| Drug | AC1L9UU3 | 2.85e-07 | 7 | 219 | 4 | CID000071762 | |
| Drug | Paramax | 2.85e-07 | 7 | 219 | 4 | CID000156411 | |
| Drug | amino-methyl | 2.85e-07 | 7 | 219 | 4 | CID000142005 | |
| Drug | ammonium sulfate | 4.02e-07 | 126 | 219 | 10 | CID000024538 | |
| Drug | AC1L88YH | 4.43e-07 | 17 | 219 | 5 | CID000374551 | |
| Drug | AC1NSVJM | 5.66e-07 | 8 | 219 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 5.66e-07 | 8 | 219 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 5.66e-07 | 8 | 219 | 4 | CID000146692 | |
| Drug | acrinor | 5.66e-07 | 8 | 219 | 4 | CID005489637 | |
| Drug | NSC300622 | 5.66e-07 | 8 | 219 | 4 | CID000028426 | |
| Drug | theodrenaline | 5.66e-07 | 8 | 219 | 4 | CID000071857 | |
| Drug | rhodanile blue | 5.66e-07 | 8 | 219 | 4 | CID000073372 | |
| Drug | trimitan | 6.09e-07 | 18 | 219 | 5 | CID000005561 | |
| Drug | P664 | 6.09e-07 | 18 | 219 | 5 | CID000107429 | |
| Drug | amylopectin | 6.41e-07 | 52 | 219 | 7 | CID000439207 | |
| Drug | AC1L9MQJ | 8.20e-07 | 19 | 219 | 5 | CID000449108 | |
| Drug | Lugol's iodine | 8.20e-07 | 19 | 219 | 5 | CID000105053 | |
| Drug | AC1N3UXZ | 8.78e-07 | 3 | 219 | 3 | CID004118625 | |
| Drug | PNPC | 9.51e-07 | 35 | 219 | 6 | CID000165125 | |
| Drug | GSAD | 1.01e-06 | 9 | 219 | 4 | CID009909127 | |
| Drug | zingiberene | 1.01e-06 | 9 | 219 | 4 | CID000092776 | |
| Drug | Atonik | 1.01e-06 | 9 | 219 | 4 | CID000069471 | |
| Drug | H 187 | 1.01e-06 | 9 | 219 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 1.01e-06 | 9 | 219 | 4 | CID000024864 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.37e-06 | 83 | 219 | 8 | CID011968896 | |
| Drug | AC1L3XPY | 1.41e-06 | 21 | 219 | 5 | CID000124005 | |
| Drug | Sudan II | 1.50e-06 | 113 | 219 | 9 | CID005354447 | |
| Drug | T694 | 1.62e-06 | 114 | 219 | 9 | CID000000872 | |
| Drug | I ZE | 1.67e-06 | 10 | 219 | 4 | CID009549200 | |
| Disease | alpha-amylase 1 measurement | 3.29e-07 | 9 | 214 | 4 | EFO_0801371 | |
| Disease | pneumonia, COVID-19 | 1.80e-04 | 113 | 214 | 6 | EFO_0003106, MONDO_0100096 | |
| Disease | response to radiation, Urinary retention | 2.37e-04 | 17 | 214 | 3 | GO_0009314, HP_0000016 | |
| Disease | N,N-dimethylalanine measurement | 3.11e-04 | 4 | 214 | 2 | EFO_0800098 | |
| Disease | Colorectal Carcinoma | ACACA BCAS2 OBSCN ZNF217 NLGN4X PTPRS ETAA1 FOXH1 PIGO FLNC KALRN WRN SIGLEC7 CHD5 | 6.55e-04 | 702 | 214 | 14 | C0009402 |
| Disease | protein CASC4 measurement | 7.70e-04 | 6 | 214 | 2 | EFO_0802927 | |
| Disease | chronic mucus hypersecretion | 1.07e-03 | 7 | 214 | 2 | EFO_0005673 | |
| Disease | peritonitis (biomarker_via_orthology) | 1.07e-03 | 7 | 214 | 2 | DOID:8283 (biomarker_via_orthology) | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.07e-03 | 7 | 214 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | Seizures | 1.11e-03 | 218 | 214 | 7 | C0036572 | |
| Disease | Liver carcinoma | A2M CYLD ACACA VCAM1 CNDP1 PAMR1 SKP2 SLC2A1 IGFALS CSMD1 HERC5 | 1.27e-03 | 507 | 214 | 11 | C2239176 |
| Disease | Liver Cirrhosis, Experimental | A2M JAK2 ADRA1B AHNAK MME CNDP1 DPP7 INHBE PAMR1 DOCK10 ZFP37 TKFC IGFALS IL2RG | 1.65e-03 | 774 | 214 | 14 | C0023893 |
| Disease | isovalerate measurement | 1.82e-03 | 9 | 214 | 2 | EFO_0021051 | |
| Disease | interferon alpha/beta receptor 1 measurement | 1.82e-03 | 9 | 214 | 2 | EFO_0021850 | |
| Disease | melanoma (is_implicated_in) | 1.91e-03 | 34 | 214 | 3 | DOID:1909 (is_implicated_in) | |
| Disease | pursuit maintenance gain measurement | 2.07e-03 | 123 | 214 | 5 | EFO_0008433 | |
| Disease | COVID-19 symptoms measurement | 2.07e-03 | 35 | 214 | 3 | EFO_0600019 | |
| Disease | response to carboplatin, response to antineoplastic agent | 2.27e-03 | 10 | 214 | 2 | GO_0097327, GO_0097328 | |
| Disease | Developmental delay (disorder) | 2.44e-03 | 37 | 214 | 3 | C0424605 | |
| Disease | response to vaccine, cytokine measurement | 2.72e-03 | 131 | 214 | 5 | EFO_0004645, EFO_0004873 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 2.76e-03 | 11 | 214 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | Global developmental delay | 2.91e-03 | 133 | 214 | 5 | C0557874 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 3.87e-03 | 13 | 214 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | IGFBP-1 measurement | 3.87e-03 | 13 | 214 | 2 | EFO_0005118 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression | 3.87e-03 | 13 | 214 | 2 | EFO_0003761, EFO_0003888 | |
| Disease | prostate carcinoma (is_implicated_in) | 3.87e-03 | 13 | 214 | 2 | DOID:10286 (is_implicated_in) | |
| Disease | left ventricular systolic function measurement | 4.00e-03 | 44 | 214 | 3 | EFO_0008206 | |
| Disease | Fanconi anemia | 4.50e-03 | 14 | 214 | 2 | cv:C0015625 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 4.50e-03 | 14 | 214 | 2 | C0677776 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 4.54e-03 | 46 | 214 | 3 | EFO_0005325, HP_0012735 | |
| Disease | longevity | 4.86e-03 | 284 | 214 | 7 | EFO_0004300 | |
| Disease | Congenital total cataract | 5.88e-03 | 16 | 214 | 2 | C0266539 | |
| Disease | cutaneous Leishmaniasis | 5.88e-03 | 16 | 214 | 2 | EFO_0005046 | |
| Disease | Generalized seizures | 6.35e-03 | 101 | 214 | 4 | C0234533 | |
| Disease | Clonic Seizures | 6.35e-03 | 101 | 214 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 6.35e-03 | 101 | 214 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 6.35e-03 | 101 | 214 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 6.35e-03 | 101 | 214 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 6.35e-03 | 101 | 214 | 4 | C0751123 | |
| Disease | Complex partial seizures | 6.35e-03 | 101 | 214 | 4 | C0149958 | |
| Disease | Single Seizure | 6.35e-03 | 101 | 214 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 6.35e-03 | 101 | 214 | 4 | C3495874 | |
| Disease | Visual seizure | 6.35e-03 | 101 | 214 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 6.35e-03 | 101 | 214 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 6.35e-03 | 101 | 214 | 4 | C0422855 | |
| Disease | Gustatory seizure | 6.35e-03 | 101 | 214 | 4 | C0422854 | |
| Disease | Seizures, Somatosensory | 6.35e-03 | 101 | 214 | 4 | C0422850 | |
| Disease | Olfactory seizure | 6.35e-03 | 101 | 214 | 4 | C0422853 | |
| Disease | Seizures, Auditory | 6.35e-03 | 101 | 214 | 4 | C0422852 | |
| Disease | Generalized Absence Seizures | 6.35e-03 | 101 | 214 | 4 | C4505436 | |
| Disease | Jacksonian Seizure | 6.35e-03 | 101 | 214 | 4 | C0022333 | |
| Disease | Epileptic Seizures | 6.35e-03 | 101 | 214 | 4 | C4317109 | |
| Disease | Absence Seizures | 6.57e-03 | 102 | 214 | 4 | C4316903 | |
| Disease | Convulsions | 6.57e-03 | 102 | 214 | 4 | C4048158 | |
| Disease | Tonic Seizures | 6.57e-03 | 102 | 214 | 4 | C0270844 | |
| Disease | Moyamoya Disease | 6.63e-03 | 17 | 214 | 2 | C0026654 | |
| Disease | response to cisplatin, platinum measurement | 6.75e-03 | 53 | 214 | 3 | EFO_0010154, GO_0072718 | |
| Disease | Seizures, Focal | 7.03e-03 | 104 | 214 | 4 | C0751495 | |
| Disease | Myoclonic Seizures | 7.03e-03 | 104 | 214 | 4 | C4317123 | |
| Disease | Tonic - clonic seizures | 7.03e-03 | 104 | 214 | 4 | C0494475 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SAGSLQNLSAGNWKF | 846 | Q99569 | |
| PDLLSQGFLQSSWKG | 476 | Q8N944 | |
| SEGQRKSPLQSWFAE | 196 | Q5NDL2 | |
| IAFAWEPNGSKFAVL | 566 | P55884 | |
| FDKQQANTIFWSPQG | 606 | P55884 | |
| NEKQPWSDFAVLNGG | 346 | Q92870 | |
| GKRQPATLTVDWFNA | 3366 | Q96PZ7 | |
| TVLGAKWREFSANNP | 186 | Q8TDI0 | |
| SQFVEWASAGNLKPV | 751 | Q8IZ83 | |
| IGLTPFLGWNSKDSA | 136 | P29275 | |
| LQASALAAWGGKAAN | 306 | P05062 | |
| WLAVDGLVSPSNNSK | 61 | P18848 | |
| TAAISNWAFIPNKNA | 196 | Q8IZF3 | |
| NWAFIPNKNASSDLL | 201 | Q8IZF3 | |
| QGAWAAPVKSQAIAQ | 11 | Q96Q83 | |
| PSLKQLNLWSTQFGD | 686 | Q8IY22 | |
| NLNSNWFPEGSKPFI | 231 | P0DTE7 | |
| NLNSNWFPEGSKPFI | 231 | P0DTE8 | |
| AAQDFFQRWKQLSLP | 871 | O95782 | |
| DNLKSNPGIKWQYFS | 176 | Q5VU97 | |
| IQQAGQVWFPDSAFK | 2011 | Q13085 | |
| FISGSFNNWSTKIPL | 91 | O43741 | |
| WSLKSSAQFLGSPQL | 36 | P49753 | |
| NLGWNSLAVLPDAAF | 176 | P35858 | |
| EWKGPQVSSALNLDT | 5596 | Q09666 | |
| TSAPAHWGELKNANF | 11 | P35368 | |
| ALPQWKQSSYAGDAI | 26 | Q8N6F1 | |
| TQALPQDSGTAAWKG | 171 | O95567 | |
| LQFPSGQNNSVKEWE | 556 | Q5JWR5 | |
| SKLWVPNTDFDVAAN | 21 | Q9BXJ7 | |
| NLNSNWFPEGSKPFI | 231 | P0DUB6 | |
| NLNSNWFPAGSKPFI | 231 | P19961 | |
| FGNTPEWNSSKFISL | 516 | P78312 | |
| VSWAVTPKSLGNVNF | 856 | P01023 | |
| PFEAQWAALEGKATV | 576 | Q9Y6R0 | |
| AESFPNWTLAQVGQK | 1551 | Q9HC84 | |
| GQAFITFPNKEIAWQ | 351 | Q96IZ5 | |
| PNITRNGAFINWKEA | 226 | Q96AA3 | |
| GSSEWLALTKSPQAF | 86 | Q8WXF3 | |
| NLPGWSLKDGNAFLD | 51 | Q9NV88 | |
| NPKNLNLATDKWSFG | 726 | O60674 | |
| PAGDGTFQKWAAVVV | 256 | P30511 | |
| AAFGKSPEIAASLWQ | 651 | Q92621 | |
| PGNAAWNLAEVEFSA | 281 | Q7Z304 | |
| NLNSNWFPAGSKPFI | 231 | P04746 | |
| VGSALKAETPNNWNA | 206 | Q86V59 | |
| KVEEWSSLGRNNFPA | 221 | P55771 | |
| PAGDGTFQKWAAVVV | 256 | P13747 | |
| VWPNLFIGDAATANN | 41 | Q6B8I1 | |
| TAVPNALAVDWIGKN | 3086 | Q9NZR2 | |
| PQAKGNFWAVDVSLI | 101 | O75593 | |
| SLISFDNPDGGVWKQ | 136 | Q16706 | |
| AKNWTFPNTRAAGSS | 1231 | Q9HCH0 | |
| LSAAVEKNPGVWLNT | 196 | O95983 | |
| PAAIAVAGFSNWTSN | 401 | P11166 | |
| KALREWATNPGLFSQ | 101 | Q15742 | |
| FVPAWLNFSTPQSAK | 6 | Q9HC44 | |
| WAASQQPASSAGKRA | 411 | O95208 | |
| ASFPGWLAMAQQKAD | 366 | Q9BQS8 | |
| NGDLKWLVNSPSLFA | 351 | Q8N0V5 | |
| LQNGAAVTDLAWDPF | 541 | P57737 | |
| FESLGKAWPRNAETQ | 1696 | Q5VYK3 | |
| SAVFSLLKANNPWPA | 296 | P58166 | |
| NPANLSGTKGKAWAF | 221 | Q8IWD5 | |
| VAPWVLSAAAGGKNL | 16 | P17181 | |
| KQWKFPDGSFIQNLS | 396 | O43660 | |
| SLQLWDTAKAAGPLQ | 91 | O00628 | |
| FNATSGKAIWTLNPN | 236 | A2RU67 | |
| WNLNGLQADLSSFKS | 111 | P06734 | |
| LPITNFNRDWQDGKA | 176 | Q14315 | |
| GDNTAEWSNLKISIP | 586 | Q8TET4 | |
| PDNFWQKQKTNFGSS | 131 | O60229 | |
| NFSLEINGKPFSWLN | 311 | P08473 | |
| INGKPFSWLNFTNEI | 316 | P08473 | |
| ADQPEAAKFRQFWGS | 571 | Q9H6R4 | |
| LVSTFDWKNNPLFVN | 906 | Q9H6R4 | |
| NGSGQPLDKKAAVSW | 86 | Q9H9L3 | |
| LGAAASLWAKTPNQG | 366 | Q86XN8 | |
| TKFPALAWVDLGNNV | 236 | Q2VPJ9 | |
| TQLATADARFWKGPS | 716 | Q9NY33 | |
| PEKFSGSSWIEFLNN | 531 | P50748 | |
| NNLLASKIWTPDTFF | 121 | P31644 | |
| QRLNAGQWFLKTDPF | 306 | Q8WTR4 | |
| ITASGQYGQWAPKLA | 2056 | P00451 | |
| LSPNGKQLATASWDT | 26 | Q8TC44 | |
| LKTAWGQQPDLAANE | 251 | Q9UNM6 | |
| NNQWPEGLKFLFDSV | 126 | O00410 | |
| GVSAAALALQWAESP | 2281 | O95613 | |
| EGSKWDLGNPAVNLS | 716 | Q6ZV29 | |
| GQKSDANAPFAQWST | 546 | Q8ND30 | |
| PKDNAWNSGIVIFNT | 646 | Q96JM4 | |
| GNLKWDDTSFNLPSN | 1476 | Q96JM4 | |
| EPGAAAASSAWKLNF | 321 | P32242 | |
| GQNDIFWDQNSPLTK | 101 | Q9NY74 | |
| GNRWTFNPAVLTKAN | 301 | Q86YT6 | |
| WTAFNLLNGKPSVAP | 1116 | Q13332 | |
| LAWQQSLSGKPADEG | 61 | Q9BX63 | |
| AKSPGAQLWLFPSAA | 26 | Q9UII4 | |
| VSAQPAAQATWSKDG | 7486 | Q5VST9 | |
| GTALSSWAVNYQPAK | 281 | Q8NFZ3 | |
| NLQQPTWGAALTAFA | 736 | A1KZ92 | |
| GTNAKTAYEWVNPAA | 1081 | Q9ULT8 | |
| WQLSKPSLASFDAIF | 631 | Q8NFZ0 | |
| KPNTGSIFNIAWSID | 266 | Q9P2H3 | |
| WFSATVINGNPASKT | 206 | Q9Y4C1 | |
| PFAWAVRSVFKDNQG | 556 | Q96BY6 | |
| AGAWVTPELASQAAA | 461 | Q8IVS8 | |
| NKWAGLLGPISNHSF | 991 | P51587 | |
| AASNLQWRPESKSGL | 3121 | P51587 | |
| SNVGESNLWPLNKFL | 631 | Q6ZN84 | |
| WKAPSDNGSKIQNFV | 391 | Q9Y2H6 | |
| NNLNPVWEAFKVSLS | 276 | Q9UBL6 | |
| DTAWRVPNGAKQADS | 56 | Q14197 | |
| NILQWESPAFAKGNL | 36 | Q08334 | |
| FLKGSNWIPADSFQD | 351 | O00462 | |
| ENVIWIGPKNALAFA | 76 | Q9HBG7 | |
| WGSNTSKENPFLFAL | 246 | P31785 | |
| DWNKLQSLSAFQPAL | 56 | Q9NS73 | |
| WGDNKAFNEVIISPA | 631 | Q9Y4D2 | |
| ITGPWAKDNFQDTLQ | 211 | P42892 | |
| WSFINSNLKFAEAPS | 736 | Q9NQC7 | |
| KNFATGAVPIAWQEE | 506 | Q8WTQ7 | |
| SGLSLEPVYWNSANK | 26 | Q15768 | |
| RAINLTWTKPFDGNS | 606 | Q58EX2 | |
| NWFPNTLNKGNLESF | 496 | A6NIM6 | |
| AWVFAKPNAIQAVGV | 156 | Q08AI6 | |
| QTAASPDEQKVFALW | 626 | Q9NVU0 | |
| GTALSSWAVNYQPAK | 281 | Q8N0W4 | |
| RAWAAALENSSPKNL | 526 | Q5VV67 | |
| AASNIIFSNGNLDPW | 406 | Q9UHL4 | |
| GAQISWKQADPFASL | 231 | Q5SR56 | |
| WEFPNFNSRSKDLLG | 566 | Q969Z0 | |
| WNVLADVRSPGFKND | 601 | Q6UXH9 | |
| ASWLQPGTALAQAFK | 576 | Q86XP0 | |
| LSWQAPAFSNGAILD | 461 | Q9UF33 | |
| LDTVQAWLSSPQKFA | 66 | Q9NPI5 | |
| AWSANATKGNFPATA | 161 | Q14D33 | |
| IWKSAQASPLLQGES | 601 | Q86VV8 | |
| ASFTLAVWLKPEQQG | 146 | O75445 | |
| SPAVVAQELWNKGAL | 151 | O94941 | |
| SWVQAFPLFQNLSSK | 656 | Q9BQF6 | |
| FFSWRTQIDSPLNGK | 56 | P19320 | |
| QLEDKFPGQSSFLWQ | 261 | Q8NFQ8 | |
| AVPANTGWGDSNNKA | 516 | Q9HCJ0 | |
| FQSLPNPKSWDFLNS | 1376 | Q8TEU7 | |
| FFQGLSTWQKTPAES | 766 | Q8NBJ9 | |
| WPFLSADEVQGLAAA | 56 | Q2M2I3 | |
| PEQSANLLKWAANSF | 206 | Q9UIC8 | |
| LNNKLSALPSWAFAN | 76 | Q8N967 | |
| KQASQNFTFTPEWGA | 331 | Q96I59 | |
| AGNAVWLNRDKTSPF | 286 | Q9Y2Z4 | |
| KQSWVLPGEEANSRF | 336 | Q96D09 | |
| FPKGATWDILNLADA | 31 | O75448 | |
| WENNPSAGAFRKTGV | 301 | Q11201 | |
| FRAGNDISWKAPVAT | 66 | Q9Y286 | |
| AVDLQWSKPTSENLG | 171 | Q9HAT2 | |
| PQAQAWQAGEDKRSS | 606 | Q8TF72 | |
| VLQKGKPGADAFQSW | 1286 | Q6ZUB1 | |
| FNVVSAWALQLGPKD | 146 | Q8NFT2 | |
| SLSKGERNFQWPVLA | 3531 | O75592 | |
| GTFSEVSLAQDPKWQ | 6 | Q07444 | |
| ASPVVALQSKWEAFG | 6 | Q5T8A7 | |
| SWDFGPQAFKLLSAV | 956 | Q14191 | |
| PGWNTDISNARAFKE | 406 | P30520 | |
| APSSGQKNDITAWQE | 91 | O75934 | |
| NAVEFLWDPAKRASA | 151 | Q9NZI6 | |
| DAAPQGVNNWLAKGL | 131 | Q9GZT8 | |
| VDNNVDVFGGASKWP | 406 | P47972 | |
| SKGNVLAWPDFLSGI | 1601 | Q4LDE5 | |
| SEPKGNPLAWQAFES | 451 | Q86YF9 | |
| PSVANAWKVNASFLL | 416 | P23515 | |
| ANPKAWINAATQIFF | 236 | Q9NP91 | |
| ALAEQGPAATAALAW | 376 | Q96A09 | |
| GQLLLDWAKQPDSSQ | 101 | Q96SE0 | |
| QATGPSANWAKAEQL | 286 | P08912 | |
| SPVGLAKWFGSDVLQ | 951 | Q9NRA8 | |
| DYETQNPKWASLNLG | 481 | A6NIR3 | |
| NEVKSVAWAPSGNLL | 106 | O76071 | |
| AWAKLQASLTPGSSN | 371 | Q9C0C6 | |
| NKGPVLAWINAVSAF | 166 | Q96KN2 | |
| GAPKQAWNSSFLEQL | 156 | Q96LP6 | |
| KLNRENFPGVSWDSL | 86 | Q13309 | |
| PAAKWQGGADTLSQT | 1811 | A4UGR9 | |
| SPKQEVWLANGAAES | 221 | O00584 | |
| LSENASNNVPFSWKI | 3701 | Q63HN8 | |
| VLAPFDFKTNPSWLN | 46 | Q5VVB8 | |
| DNPKAEGLFWQTLRN | 1006 | Q9NR97 | |
| PGLKAADNESAGQWV | 771 | Q70EL2 | |
| LWQEAKAVATAQAPG | 2306 | Q99973 | |
| ALLYAAGWSPEKQAQ | 951 | P41226 | |
| QFFVTLAPTQWLDGK | 111 | Q9Y3C6 | |
| LLSFPDSNGKAIWTA | 26 | Q8N7C7 | |
| GAAELLKAWQPAESG | 246 | O14813 | |
| QSVFSGNPSIWLKDL | 131 | Q6NUQ4 | |
| EDGAWAQTFPASVLQ | 1786 | Q6ZS81 | |
| PREGTAFNISSWDKN | 891 | Q5JSZ5 | |
| AFNISSWDKNGSPNK | 896 | Q5JSZ5 | |
| GKWPFSLSEQQLDAR | 221 | Q96L92 | |
| TAINKAQNGAPSWSA | 526 | Q9NRE2 | |
| QWEAFVSGPLAETNK | 501 | Q9UPN7 | |
| LGQAQGSAPWTSAFK | 736 | Q3C1V9 | |
| TELEQYLNWKGPASA | 431 | Q53FD0 | |
| LEAGNGLPSWKFNDQ | 801 | Q17R98 | |
| PSSDAQDKQFGTWRL | 166 | Q99598 | |
| NGQAAAIKALPTDWL | 1021 | Q9H6S0 | |
| KVGSIPANAADDGQW | 2376 | Q9Y4G6 | |
| DPFTTFQAWQLATKG | 291 | O75362 | |
| DYQWLLQSPKGAEAT | 406 | Q8TEQ8 | |
| APKGLWSQNQLASSS | 301 | Q9Y2Y4 | |
| FDSNNRKWTALHPGA | 151 | Q9BZM6 | |
| PLSQDEGSLWNKFFQ | 141 | Q92609 | |
| EGLPVGAQADQASWK | 591 | Q8N3L3 | |
| SLEEAPNNWVGTFKT | 771 | P52746 | |
| NSAFLFWPLKEADTQ | 1181 | Q502W6 | |
| SAWSVNNFLITGPKA | 21 | Q9H1J5 | |
| NFSNSWPLKSFEGLS | 846 | Q9Y4F4 | |
| FGQAAWATAIPRLEK | 51 | Q1A5X7 | |
| AAGQELQAWKSPGAD | 501 | Q3LXA3 | |
| LSGNPKLNWAGAEVF | 261 | Q8WUA8 | |
| NASFNIKWIEAGPVV | 116 | Q13308 | |
| TLKALWNLTDGSPAA | 536 | Q6WRX3 | |
| ASAAEWKQLDPAQSN | 41 | Q9Y6Q3 | |
| SWNFNFPNIRDAIKL | 61 | Q96HE9 | |
| SRPSKLADFWGNNNE | 31 | Q6ICL3 | |
| QPWAEDNKVASVSGL | 266 | O43763 | |
| GWPNGLTVDKASSQL | 1211 | O75096 | |
| NWSAQTIGPDDAKAG | 96 | Q86W24 | |
| PPNWQGAEKDAAFLA | 46 | P20592 |